-
1
-
-
0017744584
-
Development of antibacterial agents of the nalidixic acid type
-
Albrecht, R. Development of antibacterial agents of the nalidixic acid type. Prog Drug Res 1977; 21: 9-104.
-
(1977)
Prog Drug Res
, vol.21
, pp. 9-104
-
-
Albrecht, R.1
-
2
-
-
33947476615
-
1,8-Naphthyridine derivaties. A new class of chemotherapeutic agents
-
Lesher, G.Y., Forelich, E.D., Gruet, M.D., Bailey, J.H., Brundage, R.P. 1,8-Naphthyridine derivaties. A new class of chemotherapeutic agents. J Med Pharm Chem 1962; 5: 1063-1068.
-
(1962)
J Med Pharm Chem
, vol.5
, pp. 1063-1068
-
-
Lesher, G.Y.1
Forelich, E.D.2
Gruet, M.D.3
Bailey, J.H.4
Brundage, R.P.5
-
3
-
-
0014020719
-
A critical evaluation of nalidixic acid in urinary-tract infections
-
Ronald, A.R., Turck, M., Petersdorf, R.G. A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med 1966; 275: 1081-1089.
-
(1966)
N Engl J Med
, vol.275
, pp. 1081-1089
-
-
Ronald, A.R.1
Turck, M.2
Petersdorf, R.G.3
-
4
-
-
1242314497
-
-
Science Press, London UK
-
Read, R.C., Morrissey, I., Ambler, J.E. Clinicians manual on respiratory tract infections and fluoroquinolones. Science Press, London UK 2000.
-
(2000)
Clinicians Manual on Respiratory Tract Infections and Fluoroquinolones
-
-
Read, R.C.1
Morrissey, I.2
Ambler, J.E.3
-
5
-
-
0019252702
-
Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids
-
Koga, H., Itoh, A., Murayama, S., Suzue, S., Irikura, T. Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. J Med Chem 1980; 23: 1358-1363.
-
(1980)
J Med Chem
, vol.23
, pp. 1358-1363
-
-
Koga, H.1
Itoh, A.2
Murayama, S.3
Suzue, S.4
Irikura, T.5
-
6
-
-
9344236011
-
Synthesis and structure-activity relationships of 2-pyridones: A novel series of potent DNA gyrase inhibitors as antibacterial agents
-
Li, Q., Chu, D.T., Claiborne, A. y cols. Synthesis and structure-activity relationships of 2-pyridones: A novel series of potent DNA gyrase inhibitors as antibacterial agents. J Med Chem 1996; 39; 3070-3088.
-
(1996)
J Med Chem
, vol.39
, pp. 3070-3088
-
-
Li, Q.1
Chu, D.T.2
Claiborne, A.3
-
7
-
-
0028316927
-
Structure-activity and structure-side-effect relationships for the quinolone antibacterials
-
Domagala, J.M. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 1994; 33: 685-706.
-
(1994)
J Antimicrob Chemother
, vol.33
, pp. 685-706
-
-
Domagala, J.M.1
-
8
-
-
0024255719
-
The 4-quinolone antibiotics: Past, present and future
-
Stein, G.E. The 4-quinolone antibiotics: Past, present and future. Pharmacotherapy 1988; 8: 301-314.
-
(1988)
Pharmacotherapy
, vol.8
, pp. 301-314
-
-
Stein, G.E.1
-
9
-
-
0029886964
-
Quinolones: Structure-activity relationships and future predictions
-
Tillotson, G.S. Quinolones: Structure-activity relationships and future predictions. J Med Microbiol 1996; 44: 320-324.
-
(1996)
J Med Microbiol
, vol.44
, pp. 320-324
-
-
Tillotson, G.S.1
-
10
-
-
0033010428
-
Fluoroquinolone toxicity profiles: A review focusing on newer agents
-
Lipsky, B.A., Baker, C.A. Fluoroquinolone toxicity profiles: A review focusing on newer agents. Clin Infect Dis 1999; 28: 352-364.
-
(1999)
Clin Infect Dis
, vol.28
, pp. 352-364
-
-
Lipsky, B.A.1
Baker, C.A.2
-
11
-
-
0033081949
-
Mechanisms of fluoroquinolone resistance
-
Hooper, D.C. Mechanisms of fluoroquinolone resistance. Drug Resis Updates 1999; 2: 38-55.
-
(1999)
Drug Resis Updates
, vol.2
, pp. 38-55
-
-
Hooper, D.C.1
-
12
-
-
0344936960
-
Novel fluoroquinolone, structure-activity and design of new potent and safe agents
-
San Francisco
-
Ledoussal, B., Almstead, J.K., Flaim, C.P. Novel fluoroquinolone, structure-activity and design of new potent and safe agents. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco 1999; F-544.
-
(1999)
39th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Ledoussal, B.1
Almstead, J.K.2
Flaim, C.P.3
-
13
-
-
0000346409
-
T-3811, a novel des-F(6)-quinolone: Synthesis and in vitro activity of 7-(isoindolin-5-yl) derivaties
-
Toronto
-
Hayashi, K., Todo, Y., Hamamoto, S., Ojima, K., Yamada, M., Kito, T. T-3811, a novel des-F(6)-quinolone: Synthesis and in vitro activity of 7-(isoindolin-5-yl) derivaties. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto 1997; F-158.
-
(1997)
37th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Hayashi, K.1
Todo, Y.2
Hamamoto, S.3
Ojima, K.4
Yamada, M.5
Kito, T.6
-
14
-
-
0034880316
-
Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development
-
Fix, A.M., Pfaller, M.A., Biedenbach, D.J., Beach, M.L., Jones, R.N. Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development. Int J Antimicrob Agents 2001; 18: 141-145.
-
(2001)
Int J Antimicrob Agents
, vol.18
, pp. 141-145
-
-
Fix, A.M.1
Pfaller, M.A.2
Biedenbach, D.J.3
Beach, M.L.4
Jones, R.N.5
-
15
-
-
0032937732
-
In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone
-
Takahata, M., Mitsuyama, J., Yamashiro, Y. y cols. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone. Antimicrob Agents Chemother 1999; 43: 1077-1084.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 1077-1084
-
-
Takahata, M.1
Mitsuyama, J.2
Yamashiro, Y.3
-
16
-
-
0036136009
-
Antipneumococcal activity of BMS 284756 compared to six other agents
-
Pankuch, G.A., Nagai, K., Davies, T.A., Jacobs, M.R., Appelbaum, P.C. Antipneumococcal activity of BMS 284756 compared to six other agents. Antimicrob Agents Chemother 2002; 46: 251-254.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 251-254
-
-
Pankuch, G.A.1
Nagai, K.2
Davies, T.A.3
Jacobs, M.R.4
Appelbaum, P.C.5
-
17
-
-
0034426122
-
Antibacterial spectrum of a novel des-fluoro(6)-quinolone, BMS284756
-
Fung-Tomc, J.C., Minassian, B., Kolek, B. y cols. Antibacterial spectrum of a novel des-fluoro(6)-quinolone, BMS284756. Antimicrob Agents Chemother 2000; 44: 3351-3356.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 3351-3356
-
-
Fung-Tomc, J.C.1
Minassian, B.2
Kolek, B.3
-
18
-
-
0035017582
-
In vitro activities of three non-fluorinated quinolones against representatives bacterial isolates
-
Barry, A.L., Fuchs, P.C., Brown, S.D. In vitro activities of three non-fluorinated quinolones against representatives bacterial isolates. Antimicrob Agents Chemother 2001; 45: 1923-1927.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 1923-1927
-
-
Barry, A.L.1
Fuchs, P.C.2
Brown, S.D.3
-
19
-
-
0034888431
-
The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues
-
Lawrence, L.E., Wu, P., Fan, L. y cols. The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues. J Antimicrob Chemother 2001; 48: 195-201.
-
(2001)
J Antimicrob Chemother
, vol.48
, pp. 195-201
-
-
Lawrence, L.E.1
Wu, P.2
Fan, L.3
-
20
-
-
0036118935
-
In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone
-
Yamakawa, T., Mitsuyama, J., Hayashi, K. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone. J Antimicrob Chemother 2002; 49: 455-465.
-
(2002)
J Antimicrob Chemother
, vol.49
, pp. 455-465
-
-
Yamakawa, T.1
Mitsuyama, J.2
Hayashi, K.3
-
21
-
-
0030061794
-
Studies on 6-aminoquinolones: Synthesis and antibacterial evaluation of 6-amino-8-methylquinolones
-
Cecchetti, V., Fravolini, A., Lorenzini, M.C., Tabarrini, O., Terni, P., Xin, T. Studies on 6-aminoquinolones: Synthesis and antibacterial evaluation of 6-amino-8-methylquinolones. J Med Chem 1996; 39: 436-445.
-
(1996)
J Med Chem
, vol.39
, pp. 436-445
-
-
Cecchetti, V.1
Fravolini, A.2
Lorenzini, M.C.3
Tabarrini, O.4
Terni, P.5
Xin, T.6
-
22
-
-
0030972785
-
Chemometric methodologies in a quantitative structure-activity relationship study: The antibacterial activity of 6-aminoquinolones
-
Cecchetti, V., Fravolini, A., Lorenzini, M.C. y cols. Chemometric methodologies in a quantitative structure-activity relationship study: The antibacterial activity of 6-aminoquinolones. J Med Chem 1997; 40: 1698-1706.
-
(1997)
J Med Chem
, vol.40
, pp. 1698-1706
-
-
Cecchetti, V.1
Fravolini, A.2
Lorenzini, M.C.3
-
23
-
-
0029922437
-
Using SAR QSAR analysis to model the activity and structure of the quinolone-DNA complex
-
Llorente, B., Leclerc, F., Cedergren, R. Using SAR and QSAR analysis to model the activity and structure of the quinolone-DNA complex. Bio Med Chem 1996; 4: 61-71.
-
(1996)
Bio Med Chem
, vol.4
, pp. 61-71
-
-
Llorente, B.1
Leclerc, F.2
Cedergren, R.3
-
24
-
-
0029955365
-
Studies on quinolone antibacterials. IV. Structure-activity relationships of antibacterial activity and side effects for 5- and 8-substitued and 5,8-disubstitued-7(3-amino-1-pyrrolidinyl)-1-cyclopropil-1,4-dihydro-4- oxoquinoline-3-carboxylic acid
-
Yoshida, T., Yamamoto, Y., Orita, H. y cols. Studies on quinolone antibacterials. IV. Structure-activity relationships of antibacterial activity and side effects for 5- and 8-substitued and 5,8-disubstitued-7(3-amino-1- pyrrolidinyl)-1-cyclopropil-1,4-dihydro-4-oxoquinoline-3-carboxylic acid. Chem Pharm Bull (Tokyo) 1996; 44: 1074-1085.
-
(1996)
Chem Pharm Bull (Tokyo)
, vol.44
, pp. 1074-1085
-
-
Yoshida, T.1
Yamamoto, Y.2
Orita, H.3
-
25
-
-
0032812518
-
Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin
-
Kahn, A.A., Araujo, F.G., Brightly, K.E., Gootz, T.D., Remington, J.S. Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin. Antimicrob Agents Chemother 1999; 43: 1783-1787.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 1783-1787
-
-
Kahn, A.A.1
Araujo, F.G.2
Brightly, K.E.3
Gootz, T.D.4
Remington, J.S.5
-
26
-
-
0033011810
-
Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: Effects of a C-8 methoxy group on survival in liquid media and in human macrophages
-
Zhao, B.Y, Pine, R., Domagala, J., Drlica, K. Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: Effects of a C-8 methoxy group on survival in liquid media and in human macrophages. Antimicrob Agents Chemother 1999; 43: 661-666.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 661-666
-
-
Zhao, B.Y.1
Pine, R.2
Domagala, J.3
Drlica, K.4
-
27
-
-
0033053495
-
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci
-
Jorgensen, J.H., Weigel, L.M., Ferraro, M.J., Swenson, J.M., Tenover, F.C. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Antimicrob Agents Chemother 1999; 43: 329-334.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 329-334
-
-
Jorgensen, J.H.1
Weigel, L.M.2
Ferraro, M.J.3
Swenson, J.M.4
Tenover, F.C.5
-
28
-
-
0031046694
-
Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: Selective targeting of gyrase or topoisomerase IV by quinolones
-
Pan, X.S., Fisher, M.L. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: Selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob Agents Chemother 1997; 41: 471-474.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 471-474
-
-
Pan, X.S.1
Fisher, M.L.2
-
29
-
-
0032930271
-
In vitro development of resistance to five quinolones and amoxicillin clavunate in Streptococcus pneumoniae
-
Davies, T.A., Pankuch, G.A., Dewasse, B.E., Jacobs, M.R., Appelbaum, P.C. In vitro development of resistance to five quinolones and amoxicillin clavunate in Streptococcus pneumoniae. Antimicrob Agents Chemother 1999; 43: 1177-1782.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 1177-1782
-
-
Davies, T.A.1
Pankuch, G.A.2
Dewasse, B.E.3
Jacobs, M.R.4
Appelbaum, P.C.5
-
30
-
-
0032839851
-
Contribution of topoisomerase IV and DNA gyrase mutation in Streptococcus pneumoniae for resistance to novel fluoroquinolones
-
Pestova, E., Beyer, R., Cianciotto, N.P., Noskin, G.A., Peterson, L.R. Contribution of topoisomerase IV and DNA gyrase mutation in Streptococcus pneumoniae for resistance to novel fluoroquinolones. Antimicrob Agents Chemother 1999; 43: 2000-2004.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 2000-2004
-
-
Pestova, E.1
Beyer, R.2
Cianciotto, N.P.3
Noskin, G.A.4
Peterson, L.R.5
-
31
-
-
0035023593
-
Contribution of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae
-
Fukuda, H., Kishii, R., Takei, M., Hosaka, M. Contribution of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae. Antimicrob Agents Chemother 2001; 45: 1649-1453.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 1649-1453
-
-
Fukuda, H.1
Kishii, R.2
Takei, M.3
Hosaka, M.4
-
32
-
-
0035867057
-
Comparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y-3118
-
Dalhoff, A. Comparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y-3118. Clin Infect Dis 2001; 32 (Suppl. 1): S16-S22.
-
(2001)
Clin Infect Dis
, vol.32
, Issue.SUPPL. 1
-
-
Dalhoff, A.1
-
33
-
-
0008450171
-
The C-8 methoxy group of moxifloxacin decreases the propensity for quinolone resistance development in Staphylococcus aureus
-
Philadelphia; Abstr. 102
-
Dalhoff, A. The C-8 methoxy group of moxifloxacin decreases the propensity for quinolone resistance development in Staphylococcus aureus. 37th Annual Meeting of the Infectious Diseases Society of America, Philadelphia 1999; Abstr. 102.
-
(1999)
37th Annual Meeting of the Infectious Diseases Society of America
-
-
Dalhoff, A.1
-
34
-
-
0028859494
-
In vitro antibacterial activity of DU-6859a, a new fluoroquinolone
-
Nakane, T., Iyobe, S., Sato, K., Mitsuhashi, S. In vitro antibacterial activity of DU-6859a, a new fluoroquinolone, Antimicrob Agents Chemother 1995; 39: 2822-2826.
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 2822-2826
-
-
Nakane, T.1
Iyobe, S.2
Sato, K.3
Mitsuhashi, S.4
-
35
-
-
0032784460
-
Structures of existing and new quinolones and relationship to bactericidal activity against Streptococcus pneumoniae
-
Mitsuyama, J. Structures of existing and new quinolones and relationship to bactericidal activity against Streptococcus pneumoniae, J Antimicrob Chemother 1999; 44: 201-207.
-
(1999)
J Antimicrob Chemother
, vol.44
, pp. 201-207
-
-
Mitsuyama, J.1
-
36
-
-
0029837525
-
Mechanism of differential activities of ofloxacin enantiomers
-
Morrissey, I., Hoshino, K., Sato, K. y cols. Mechanism of differential activities of ofloxacin enantiomers. Antimicrob Agents Chemother 1996; 40: 1775-1784.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 1775-1784
-
-
Morrissey, I.1
Hoshino, K.2
Sato, K.3
-
37
-
-
10144258659
-
Structure-activity relationships of quinolone agents against mycobacteria: Effect of structural modifications at the 8 position
-
Renau, T.E., Gage, J.W., Dever, J.A. y cols. Structure-activity relationships of quinolone agents against mycobacteria: Effect of structural modifications at the 8 position. Antimicrob Agents Chemother 1996; 40: 2363-2368.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 2363-2368
-
-
Renau, T.E.1
Gage, J.W.2
Dever, J.A.3
-
38
-
-
0035884910
-
Quinolone molecular structure-activity relationships: What we have learned about improving antimicrobial activity?
-
Peterson, L.R. Quinolone molecular structure-activity relationships: What we have learned about improving antimicrobial activity? Clin Infect Dis 2001; 33 (Supl. 3): S180-S186.
-
(2001)
Clin Infect Dis
, vol.33
, Issue.SUPPL. 3
-
-
Peterson, L.R.1
-
39
-
-
0031755687
-
Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract
-
Piddock, L.J., Jonhson, M., Ricci, V., Hill, S.L. Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Antimicrob Agents Chemother 1998; 42: 2956-2960.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 2956-2960
-
-
Piddock, L.J.1
Jonhson, M.2
Ricci, V.3
Hill, S.L.4
-
40
-
-
0031685173
-
Advances in the macrolides and quinolones
-
Boswell, F.J., Wise R. Advances in the macrolides and quinolones. Infect Dis Clin North Am 1998; 12: 647-670.
-
(1998)
Infect Dis Clin North Am
, vol.12
, pp. 647-670
-
-
Boswell, F.J.1
Wise, R.2
-
41
-
-
0345337645
-
SB-265805 (LB20304a): Structure-activity relationship of the oxime-derivatized pyrrolidine. The importance of the oximinoalkyl group on in vitro antibacterial activity and pharmacokinetics
-
San Diego
-
Hong, C.Y., Kim, Y.K., Nam, D.-H. y cols. SB-265805 (LB20304a): Structure-activity relationship of the oxime-derivatized pyrrolidine. The importance of the oximinoalkyl group on in vitro antibacterial activity and pharmacokinetics. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego 1998; F-095.
-
(1998)
38th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Hong, C.Y.1
Kim, Y.K.2
Nam, D.-H.3
-
42
-
-
0344474928
-
SB-265805 (LB20304a): The synergistic effect of the methyloxime and aminomethyl groups of the C7-pyrrolidine on in vitro activity
-
San Diego
-
Hong, C.Y., Kim, Y.K., Jang, J.H., Kim, M.Y. SB-265805 (LB20304a): The synergistic effect of the methyloxime and aminomethyl groups of the C7-pyrrolidine on in vitro activity. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego 1998; F-096.
-
(1998)
38th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Hong, C.Y.1
Kim, Y.K.2
Jang, J.H.3
Kim, M.Y.4
-
43
-
-
0033839497
-
The fluoroquinolones antibacterials: Past, present and future perspectives
-
Appelbaum, P.C., Hunter, P.A. The fluoroquinolones antibacterials: Past, present and future perspectives. Int J Antimicrb Agents 2000; 16: 5-15.
-
(2000)
Int J Antimicrb Agents
, vol.16
, pp. 5-15
-
-
Appelbaum, P.C.1
Hunter, P.A.2
-
44
-
-
0034017776
-
Intracellular targets of moxifloxacin: A comparison with other fluoroquinolones
-
Pestova, E., Millichap, J.J., Noskin, G.A., Peterson, L.R. Intracellular targets of moxifloxacin: A comparison with other fluoroquinolones. J Antimicrob Chemother 2000; 45: 583-590.
-
(2000)
J Antimicrob Chemother
, vol.45
, pp. 583-590
-
-
Pestova, E.1
Millichap, J.J.2
Noskin, G.A.3
Peterson, L.R.4
-
45
-
-
0033993695
-
A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: Evidence for disminished moxifloxacin, sparfloxacin and trovafloxacin efflux
-
Beyer, R., Pestova, E., Millichap, J.J., Noskin, G.A., Peterson, L.R. A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: Evidence for disminished moxifloxacin, sparfloxacin and trovafloxacin efflux. Antimicrob Agents Chemother 2000; 44: 798-801.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 798-801
-
-
Beyer, R.1
Pestova, E.2
Millichap, J.J.3
Noskin, G.A.4
Peterson, L.R.5
-
46
-
-
0033977308
-
Antipneumococcal activities of gemifloxacin compared to those of nine other agents
-
Davies, T.A., Kelly, L.M., Pankuch, G.A., Credito, K.L., Jacobs, M.R., Appelbaum, P.C. Antipneumococcal activities of gemifloxacin compared to those of nine other agents. Antimicrob Agents Chemother 2000; 44: 304-310.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 304-310
-
-
Davies, T.A.1
Kelly, L.M.2
Pankuch, G.A.3
Credito, K.L.4
Jacobs, M.R.5
Appelbaum, P.C.6
-
47
-
-
0033979885
-
Engineering the specifity of antibacterial fluoroquinolones: Benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase
-
Alovero, F.L., Pan, X.S., Morris, J.A., Manzo, R.H., Fisher, L.M. Engineering the specifity of antibacterial fluoroquinolones: Benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase. Antimicrob Agents Chemother 2000; 44: 320-325.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 320-325
-
-
Alovero, F.L.1
Pan, X.S.2
Morris, J.A.3
Manzo, R.H.4
Fisher, L.M.5
-
48
-
-
0032957758
-
Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae
-
Lister, P.D., Sanders, C.C. Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae. J Antimicrob Chemother 1999; 43: 79-86.
-
(1999)
J Antimicrob Chemother
, vol.43
, pp. 79-86
-
-
Lister, P.D.1
Sanders, C.C.2
-
49
-
-
0033533871
-
Synthesis and antimicrobial activity oh 4-H-4-oxoquinolizines derivaties: Consequences of structural modifications at the C-8 position
-
Ma, Z., Chu, D.T., Cooper, C.S. y cols. Synthesis and antimicrobial activity oh 4-H-4-oxoquinolizines derivaties: Consequences of structural modifications at the C-8 position. J Med Chem 1999; 42: 4203-4213.
-
(1999)
J Med Chem
, vol.42
, pp. 4203-4213
-
-
Ma, Z.1
Chu, D.T.2
Cooper, C.S.3
-
50
-
-
0342646918
-
The 2-pyridone antibacterial agents: Bacterial topoisomerase inhibitors
-
Li, Q., Mitscher, L.A., Shen, L.L. The 2-pyridone antibacterial agents: Bacterial topoisomerase inhibitors. Med Res Rev 2000; 20: 231-293.
-
(2000)
Med Res Rev
, vol.20
, pp. 231-293
-
-
Li, Q.1
Mitscher, L.A.2
Shen, L.L.3
-
51
-
-
10544254692
-
Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases
-
Blanche, F., Cameron, B., Bernard, F.X. y cols. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Antimicrob Agents Chemother 1996; 40: 2714-2720.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 2714-2720
-
-
Blanche, F.1
Cameron, B.2
Bernard, F.X.3
-
52
-
-
0344906436
-
Comparative in vitro antibacterial activity of A-170568.1, a novel 2-pyridone antibacterial agent
-
San Diego
-
Nilius, A.M., Hensey-Rudloff, D.M., Almer, L.S. y cols. Comparative in vitro antibacterial activity of A-170568.1, a novel 2-pyridone antibacterial agent. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego 1998; F-79.
-
(1998)
38th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Nilius, A.M.1
Hensey-Rudloff, D.M.2
Almer, L.S.3
-
53
-
-
0342573213
-
The discovery of A-165753 and A-170568, two potent broad-spectrum antimicrobial agents
-
San Diego
-
Amiger, Y-L., Chu, D.T.W., Fung, A.K.L. y cols. The discovery of A-165753 and A-170568, two potent broad-spectrum antimicrobial agents. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego 1998; F-86.
-
(1998)
38th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Amiger, Y.-L.1
Chu, D.T.W.2
Fung, A.K.L.3
-
54
-
-
0343007415
-
Comparative in vitro activity of A-86719.1, a novel bacterial DNA gyrase inhibitor
-
Washington DC
-
Flamm, R.K., Vojtko, C., Ramer, N. y cols. Comparative in vitro activity of A-86719.1, a novel bacterial DNA gyrase inhibitor. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC 1994; F-45.
-
(1994)
34th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Flamm, R.K.1
Vojtko, C.2
Ramer, N.3
-
55
-
-
0028818518
-
Tolerability of fluoroquinolone antibiotics: Past, present and future
-
Ball, P., Tillotson, G. Tolerability of fluoroquinolone antibiotics: Past, present and future. Drug Safety 1995; 13: 343-358.
-
(1995)
Drug Safety
, vol.13
, pp. 343-358
-
-
Ball, P.1
Tillotson, G.2
-
56
-
-
0025859183
-
Rheumatological side-effects of quinolones
-
Kahn, M.F. (Ed.). Baillière Tindall, London
-
Ribard, P., Kahn, M.F. Rheumatological side-effects of quinolones. En: Kahn, M.F. (Ed.). Baillière's clinical rheumatology: Drug induced rheumatic diseases. Baillière Tindall, London 1991; 175-191.
-
(1991)
Baillière's Clinical Rheumatology: Drug Induced Rheumatic Diseases
, pp. 175-191
-
-
Ribard, P.1
Kahn, M.F.2
-
57
-
-
0029142723
-
Classification and structure-activity relationships of fluoroquinolones
-
Bryskier, A., Chantot, J.F. Classification and structure-activity relationships of fluoroquinolones. Drug 1995; 49 (Suppl. 2): 16-28.
-
(1995)
Drug
, vol.49
, Issue.SUPPL. 2
, pp. 16-28
-
-
Bryskier, A.1
Chantot, J.F.2
-
58
-
-
0025876187
-
Quinolone-cation interactions: A review. DICP
-
Lomaestro, B.M., Bailie, G.R. Quinolone-cation interactions: A review. DICP. Ann Pharmacother 1991; 25: 1249-1258.
-
(1991)
Ann Pharmacother
, vol.25
, pp. 1249-1258
-
-
Lomaestro, B.M.1
Bailie, G.R.2
-
59
-
-
0002113676
-
Pharmacokinetics and tissue penetration of fluoroquinolones
-
Sanders, E.W., Sanders, C.C. (Eds.). Physicians and Scientist Publ. Co., Glenview, IL
-
Shentag, J.J., Nix, D.E. Pharmacokinetics and tissue penetration of fluoroquinolones. En: Sanders, E.W., Sanders, C.C. (Eds.). Fluoroquinolones in the treatment of infectious diseases. Physicians and Scientist Publ. Co., Glenview, IL 1990; 29-44.
-
(1990)
Fluoroquinolones in the Treatment of Infectious Diseases
, pp. 29-44
-
-
Shentag, J.J.1
Nix, D.E.2
-
60
-
-
0026341296
-
Overview of fluoroquinolone safety
-
Wolfson, J.S., Hooper, D.C. Overview of fluoroquinolone safety. Am J Med 1991; 91 (Suppl. 6A): 153S-161S.
-
(1991)
Am J Med
, vol.91
, Issue.SUPPL. 6A
-
-
Wolfson, J.S.1
Hooper, D.C.2
-
63
-
-
0026576555
-
Mutagenicity of quinolone antibacterials
-
Fort, F.L. Mutagenicity of quinolone antibacterials. Drug Safety 1992; 7: 214-222.
-
(1992)
Drug Safety
, vol.7
, pp. 214-222
-
-
Fort, F.L.1
-
64
-
-
0025869379
-
Side effects of quinolones: Comparison between quinolones and other antibiotics
-
Norrby, S.R. Side effects of quinolones: Comparison between quinolones and other antibiotics. Eur J Clin Microbiol Infect Dis 1991; 10: 378-383.
-
(1991)
Eur J Clin Microbiol Infect Dis
, vol.10
, pp. 378-383
-
-
Norrby, S.R.1
-
65
-
-
0023740775
-
Design, synthesis, and properties of (4S)-7-(4-amino-2-substitued- pyrrolinyl) quinolone-3-carboxylic acids
-
Rosen, T., Chu, D.T.W., Lico, I.M., Fernandes, P.B., Marsh, K., Shen, L. Design, synthesis, and properties of (4S)-7-(4-amino-2-substitued-pyrrolinyl) quinolone-3-carboxylic acids. J Med Chem 1988; 31: 1598-1611.
-
(1988)
J Med Chem
, vol.31
, pp. 1598-1611
-
-
Rosen, T.1
Chu, D.T.W.2
Lico, I.M.3
Fernandes, P.B.4
Marsh, K.5
Shen, L.6
-
66
-
-
0023716946
-
Specific toxicologic aspects of the quinolones
-
Christ, W., Lehnert, T., Ulbrich, B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988; 10 (Suppl. 1): S141-S146.
-
(1988)
Rev Infect Dis
, vol.10
, Issue.SUPPL. 1
-
-
Christ, W.1
Lehnert, T.2
Ulbrich, B.3
-
68
-
-
0001743848
-
Advers effects of the fluoroquinolones
-
Halkin, H. Advers effects of the fluoroquinolones. Rev Infect Dis 1988; 10 (Suppl. 1): S258-S261.
-
(1988)
Rev Infect Dis
, vol.10
, Issue.SUPPL. 1
-
-
Halkin, H.1
|